Semaglutide dosing typically follows a gradual titration schedule
Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al
Raw, unthresholded statistical maps are publicly available on NeuroVault ( Study approval The trial protocol and drug were approved by the ethics committee of North, West, and Central Switzerland (EKNZ, Basel, Switzerland) and the national agency for the authorization and supervision of therapeutic products (Swissmedic, Berne, Switzerland)
Patients experiencing nausea, vomiting, or diarrheacommon side effects, especially during dose initiation or escalationmay inadvertently decrease their consumption of both food and beverages while experiencing increased fluid losses, resulting in dehydration that manifests as oral dryness